Maintained immunogenicity of chronic myeloid leukemia-derived dendritic cells in the presence of Imatinib mesylate: Implication for vaccination regimens [10]

T. M. Westers*, J. J.W.M. Janssen, I. Houtenbos, N. C.L. Snoijs, A. A. van de Loosdrecht, G. J. Ossenkoppele

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)154-157
Number of pages4
Issue number1
Publication statusPublished - Jan 2006

Cite this